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Abstract
Introduction: Brazil has high levels of TB-AIDS co-infection.
Objective: To analyse differences and similarities, with respect to 
each State in Brazil and to the Federal District, concerning the stage 
at which TB-AIDS co-infection treatment is discontinued. The study 
period was 2008-13.
Methods: Cross-sectional, quantitative study, using data from the 
Diseases and Notification Information System administered by the 
Brazilian Health Ministry. The data were analysed using the statistics 
program R, and the results are represented graphically by dotplots 
and dendrograms.
Results: 58,704 cases of tuberculosis-AIDS co-infection were recor-
ded. Rates of cure were under 30%. In the States of Paraíba and Per-
nambuco, treatment dropout was almost 50%.Mortality levels were 
high, at 70-90% in some States. Multiresistant TB was observed in 
less than 20%of cases. The rate of non-treated/non-resolved cases 
was 70% in Bahia. Transfer rates varied widely, with the highest level 
being recorded in Alagoas (80% of cases).
Conclusion: Global goals are far from being met. There is conside-
rable operational diversity in the public health policies of the different 
States. TB-AIDS co-infection should be monitored continuously and 
the epidemiological information system regularly updated in order to 
control this double epidemic.
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Introduction
Tuberculosis (TB) is an infectious disease that has 
been known since antiquity It has a major impact 
on public health worldwide. By the mid-1980s, the 
global epidemiological situation had been brought 
under control, but with the appearance of human 
immunodeficiency virus (HIV) infection and of acqui-
red immunodeficiency syndrome (AIDS), there has 
been a resurgence of TB [1]. Nowadays, it is consi-
dered the second main cause of death by infectious 
disease in the world, after AIDS, and the first cause 
of death among AIDS patients [2, 3].
One third of the world’s population is infected 
by the TB bacillus, and 30 million of them may die 
of this cause in the next ten years. HIV-AIDS is one 
of the main obstacles to controlling the disease [2, 
4]. Individuals infected by HIV are 50 times more 
likely to contract TB than those who are not infec-
ted [5]. This co-infection is reciprocal and generates 
a vicious circle, accelerating the pathogenic course 
of the microorganisms involved and favouring the 
appearance of drug-resistant strains [6]. 
HIV infection accelerates latent TB activation by 
depressing the immune system, and favours the ra-
pid reproduction of the bacillus. In turn, TB further 
accentuates immune depression and accelerates the 
evolution of HIV infection into AIDS, activating and 
destroying macrophages and T lymphocytes infec-
ted by the virus. The probability of death and of 
contracting other diseases is higher in co-infected 
patients than in those with either disease alone 
[3].  
The global strategy to combat TB, established by 
the WHO in 2006, aimed to eliminate it as a pu-
blic health problem by 2015, reducing the global 
incidence by 50%, detecting 70% of cases, curing 
at least 85% of new cases, reducing treatment 
dropout, reducing death rates to under 5% and 
preventing the rise of drug-resistant bacilli and co-
infection by HIV-AIDS [7, 8]. 
In Brazil, access to antiretroviral and TB treatment 
has extended throughout the population in the last 
two decades. Since 1999, in view of the widespread 
presence of TB-HIV co-infection, the National Plan 
for Tuberculosis Control has recommended anti-HIV 
tests should be performed for all TB patients. The 
Plan also stresses the importance of monitoring 
HIV-AIDS patients to identify symptoms of TB and 
of detecting the disease at the earliest possible sta-
ge, providing adequate treatment and preventing 
opportunistic diseases [7]. 
Ensuring that the necessary diagnostic tests are 
carried out should be a joint commitment entered 
into by patients and the health system, and health 
service managers must provide the necessary con-
ditions for this to take place [9]. 
Although the importance of testing anti-HIV in 
TB patients is well known, studies have highlighted 
the low frequency of requests for such tests in Bra-
zil, and this shortcoming limits our perceptions of 
the real occurrence of TB-HIV co-infection [10, 11].
In view of the above considerations regarding 
the TB-AIDS epidemic and the lack of information 
about its distribution and treatment in Brazil, the 
aim of the present study is to analyse the situation 
in the individual States and in the Federal District, in 
relation to TB-AIDS co-infection and the conclusion 
of treatment, during the period 2008-2013.
Methods
A cross-sectional, quantitative study was perfor-
med. The study population was composed of all 
the TB-AIDS cases notified from 2008 to 2013 in 
the 27 States of Brazil, namely Acre (AC), Alagoas 
(AL), Amapá (AP), Amazonas (AM), Bahia (BA), Cea-
rá (CE), Espírito Santo (ES), Goiás (GO), Maranhão 
(MA), Mato Grosso (MT), Mato Grosso do Sul (MS), 
Minas Gerais (MG), Pará (PA), Paraíba (PB), Paraná 
(PR), Pernambuco (PE), Piauí (PI), Rio de Janeiro (RJ), 
Rio Grande do Norte (RN), Rio Grande do Sul (RS), 
Rondônia (RO), Roraima (RR), Santa Catarina (SC), 
São Paulo (SP), Sergipe (SE), Tocantins (TO) together 
with the Federal District (DF). 
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The study data were obtained in June 2015, from 
the Diseases and Notification Information System, 
online version, available at the website of the Bra-
zilian Ministry of Health [12]. Statistical analysis was 
performed using the statistics program R, version 
3.2.0 [13]. 
The variables addressed described all situations in 
which TB-AIDS co-infection treatment was ended: 
non-treated/non-resolved cases, cure, dropout, 
death by TB, death by other causes, transfer and 
multi-drug-resistant TB (MDR-TB). The data obtai-
ned were analysed using a dot plot (a one-dimen-
sional graph of dispersion).
In our analysis, the dotplot shows the distribution 
of the variables and their degree of dispersion. The 
values are represented by dots along a line, distri-
buted according to a specific scale. When the data 
are homogeneous, the dots are closely grouped, 
and when they are dispersed, the dots are disper-
sed [14].
In order to analyse the degree of similarity among 
the States, regarding the distribution of TB-AIDS ca-
ses, the hierarchical clustering method (dendrogram) 
was applied, in which distances between pairs of 
States were determined by the nearest-neighbour 
method; thus, an element was associated with a 
given cluster if there was a similarity with any other 
element in that cluster. The first two cases com-
bined are those with the shortest distance or the 
maximum similarity.
The distance between two clusters was calcula-
ted as follows: d’(bi, bj U bk) = min (d(bj, bi), d(bk, 
bi)), in which i, j and k are the States and the Fede-
ral District for i ≠ j. A is a cluster of the 27 States, 
from which a Euclidean distance was calculated, 
and D=(δij)1 ≤ i,j ≤ n is the matrix of distance bet-
ween these States. The aim of the cluster analysis 
is to achieve a non-supervised classification of A 
elements, that is, to group the elements into disjoint 
classes. If these classes group successively in higher-
level classes, the result is a hierarchical structure of 
clusters, which can be graphically represented by a 
dendrogram. 
The cophenetic correlation coefficient was then 
calculated. This is a simple test to validate a group 
by measuring the degree of preservation of para-
llel distances in the dendrogram obtained from the 
association of States, compared to the original dis-
tances [15, 16, 17]. 
The silhouette mean is an indicator of the maxi-
misation of a partition. The peak of the silhouette 
mean marks the point at which the data cluste-
ring determined by the algorithm is appropriate.
We also used the Rand index, showing the pro-
portion of all pairs of States in which two different 
partitions may be correlated, i.e. whether a pair of 
States is assigned to the same group in both situa-
tions or is assigned to different groups [18]. 
This study was approved by the research ethics 
committee of the Universidade Estadual da Paraíba 
(Register No. 45954315.5.0000.5187), in accordan-
ce with Resolution 466/2012 of the National Health 
Council, the regulatory body for research with hu-
man beings in Brazil.
Results 
During the study period, 526,561 cases of TB were 
registered in Brazil, of which 58,704 cases were 
TB-AIDS co-infections. The reasons for ending TB 
treatment are shown in Figure 1, by proportions, 
for each State.
In most States, TB was cured in less than 15% of 
cases, but in RR and AP this value was approxima-
tely 20% and in AC it was 33% (Figure 1). 
In 14 States, the rate of treatment dropout was 
below5%, and in most of the rest it ranged from 
8% to 20%. However, PE and PB recorded almost 
50% (Figure 1). 
Death rates by TB varied considerably. In most 
cases, the level was below 5% but in SE, RN, TO 
and AC it rose to 10%, in GO and MT to 20%, in 
PB and AP to 30%, in MA and TO to approximately 
50% and in PA to 70% of all cases recorded. 
The variable ‘Death by other causes’ also varied 
widely (Figure 1). In MT, ES, SE, AL, RN and RR, this 
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level was below 5% while GO, SP and RJ reported 
almost 70% of cases under this description, and in 
DF the value rose to 90% of all cases. 
Regarding the transfer of TB cases, the values 
recorded ranged from 0% in RJ, PB, PI and PA to 
80% in AL. 
In all the States, MDR-TB was present at levels of 
less than 20%, with most States recording around 
5% and the highest levels being found in BA, PB 
and MA. 
Situations in which TB was non-treated/non-re-
solved were recorded in less than 5% of cases in 
most States, with the highest levels being registered 
in RJ, AC, SP, ES and MG with up to 30% and in 
BA with approximately70% (see Figure 1). 
With respect to the similarity of distribution of 
TB-AIDS co-infection cases, Figure 2 illustrates the 
formation of three large clusters, among which 
cluster SP has the highest number of cases and 
Figure 1: Death by other causes, Transfer, MDR-TB, Not identified, Cure, Abandonment, death by TB.
Figure 2:  Distribution of TB-AIDS cases in the States 
and the Federal District, 2008-2013.
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incorporates all the other States; RJ and RS pre-
sent the greatest distance from the others, except 
SP, which shows that the largest numbers of TB-
AIDS cases are recorded in the south-east of the 
country.
The cophenetic coefficient was fairly high (0.789), 
which reflects the good quality of the group. 
Figure 3 shows the variation of the adjusted Rand 
index, comparing several pairs of clusters; in this 
case, the variation of 2 or 3 clusters reached a sa-
tisfactory level (from 0.9 to 1.0), which suggests 
there is a strong degree of correspondence in each 
cluster. 
To better visualise the subgroups in the third clus-
ter, a cutoff was performed at point 1200 on the 
distance axis of the dendrogram (see Figure 2), as a 
result of which SP, RJ and RS were eliminated. The 
Rand index was calculated again and four clusters 
were formed. 
Again, the cophenetic correlation coeficient value 
was fairly high (0.78), reflecting the good quality 
of the group. The adjusted Rand index was also 
satisfactory, ranging from 0.87 to 1, considering the 
four clusters (see Figure 4). 
Figure 4:  Dendrogram for all the States except SP, 
RJ and RS.
Figure 3:  Rand index and number of groups
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Discussion
In this study, we show that the goals set by the 
WHO regarding the control of TB are not being 
met in Brazil. Although the country guarantees uni-
versal access to TB and antiretroviral drugs, free of 
charge, and despite the therapeutic and diagnos-
tic advances that have been made, the incidence 
of TB-AIDS co-infection remains unacceptably high 
[19, 20]. Thus it remains necessary to expand the 
screening programme to detect HIV in TB patients 
and vice versa, to ensure early treatment and reduce 
co-infection [7]. 
However, these strategies in themselves are not 
enough to reduce the level of TB-AIDS in Brazil; it 
is also necessary to design and implement actions 
to reduce social inequalities, to extend access to 
health services and to strengthen policies of social 
inclusion, taking into account that this epidemic has 
a major effect on the poorest groups within society 
[21, 22]. 
It is also necessary to increase our epidemiologi-
cal knowledge of TB-AIDS co-infection, so that both 
infections can be treated specifically, as this patient 
group is three times more vulnerable to therapeutic 
failure than are non co-infected patients [23, 24]. 
Rates of cure in Brazil are below the level recom-
mended by the WHO (85%), a situation that may 
contribute to the transmission of drug-resistant ba-
cilli and increase the time and cost of treatment [7]. 
Results for treatment dropout were generally 
poor, although some States reached the global 
goal, of 5% or less; furthermore, levels of cure were 
low and mortality rates were high. A high level of 
treatment dropout is associated with greater spread 
of the disease and with the appearance of bacilli 
that are resistant to TB drugs, and is considered a 
major factor in death from TB [7, 25, 26, 27]. 
In line with previous research, we found that co-
infected patients presented high levels of mortality, 
reaching 50-90% in MA, TO, PA, GO, Spain, RJ and 
DF. Thus, it is evident that TB is one of the main cau-
ses of mortality in patients with AIDS. Apart from 
treatment dropout, immune depression and multi-
resistant TB aggravate the probability of mortality 
[4, 23, 28]. 
In this context, the monitoring and periodic up-
dating of TB and AIDS information systems are 
essential to enable a proper evaluation of the in-
terventions carried out, so that appropriate public 
health actions to control these diseases can be im-
plemented, and to reveal which population groups 
are most vulnerable to co-infection [23, 29]. 
The situation in BA is especially significant becau-
se this State failed to identify the reasons for ending 
treatment in 70% of TB cases. In this respect, too, 
AL reported 80% of transfer cases, and did not 
report precise information about the reasons for en-
ding TB treatment. These shortcomings greatly limit 
the value of the data reported, making it impossi-
ble to determine exactly how these TB cases are 
concluded, and hampering the planning of control 
policies [30]. 
In Brazil, there are large variations in the inciden-
ce of TB-AIDS cases and in the treatment provided 
in the States, due to major differences between the 
regions and in the public health policies applied. 
The States of RJ and SP contain the highest levels 
of TB in the country, while RS has extremely high 
levels of patients co-infected by TB-AIDS [10, 30, 
31, 32, 33]. 
Further studies are needed to determine the spe-
cific characteristics of each State in order to achie-
ve a synergy of health actions and to enhance the 
treatment and control of these two diseases.
Detailed epidemiological knowledge about the 
situations in which the treatment of TB-AIDS co-in-
fection is concluded is essential so that health servi-
ce managers and personnel can recognise cases and 
take prompt action to remedy low rates of access to 
treatment and to improve strategies to control the 
disease. This study shows that the present situation 
regarding the reporting of reasons for the conclu-
sion of treatment is unsatisfactory, and that Brazil 
is failing to meet the WHO targets for reducing the 
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impact of TB. Variations among the States can be 
explained by regional differences and by the diver-
sity of local policies applied.
There is a need for continuous monitoring of 
cases of TB and AIDS by health services, and for 
data obtained from epidemiological surveillance in-
formation systems in each Brazilian city and State 
to be regularly updated, in order to reflect the real 
extension of this comorbidity and its particularities, 
nationwide, so that health actions can be improved 
and the best use made of available resources.
Conclusion
The situation in BA is especially significant becau- se 
this State failed to identify the reasons for ending 
treatment in 70% of TB cases. In this respect, too, 
AL reported 80% of transfer cases, and did not 
report precise information about the reasons for en- 
ding TB treatment. These shortcomings greatly limit 
the value of the data reported, making it impossi- 
ble to determine exactly how these TB cases are 
concluded, and hampering the planning of control 
policies [30]. 
In Brazil, there are large variations in the incidence 
of TB-AIDS cases and in the treatment provided in 
the States, due to major differences between the 
regions and in the public health policies applied. 
The States of RJ and SP contain the highest levels 
of TB in the country, while RS has extremely high 
levels of patients co-infected by TB-AIDS [10, 30, 
31, 32, 33]. 
Further studies are needed to determine the spe- 
cific characteristics of each State in order to achie- 
ve a synergy of health actions and to enhance the 
treatment and control of these two diseases. 
Detailed epidemiological knowledge about the 
situations in which the treatment of TB-AIDS co-in- 
fection is concluded is essential so that health servi- 
ce managers and personnel can recognise cases and 
take prompt action to remedy low rates of access to 
treatment and to improve strategies to control the 
disease. This study shows that the present situation 
regarding the reporting of reasons for the conclu- 
sion of treatment is unsatisfactory, and that Brazil 
is failing to meet the WHO targets for reducing the 
impact of TB. Variations among the States can be 
explained by regional differences and by the diver- 
sity of local policies applied.
There is a need for continuous monitoring of ca-
ses of TB and AIDS by health services, and for data 
obtained from epidemiological surveillance in- for-
mation systems in each Brazilian city and State to 
be regularly updated, in order to reflect the real 
extension of this comorbidity and its particularities, 
nationwide, so that health actions can be improved 
and the best use made of available resources.
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